Patients with atrial fibrillation (AF) who are treated with tirzepatide had lower all-cause mortality, are less likely to require rhythm control, and have fewer adverse cardiac events, according ...

Atrial fibrillation (AF), which causes an irregular heartbeat, is estimated to affect between 2% to 3% of the general population, with prevalence rising with age Previous studies on link between ...

Get Instant Summarized Text (Gist) Two studies have significantly expanded the known genetic variants associated with atrial fibrillation (AF), identifying over 350 common DNA variants and rare ...

Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation. New England Journal of Medicine , 2025; 392 (4): 361 DOI: 10.1056/NEJMoa2406674 Cite This Page : ...

One of my favorite devices launched in 2024 was the Samsung Galaxy Ring. It was first teased last January at the Galaxy S24 launch, and then Samsung gave us a sneak peek in February before ...

Does walking reduce your risk of atrial fibrillation? According to this study, yes. The researchers found that moderate-to-vigorous exercise—which can include brisk walking, ...

This device is cleared by the FDA as a clinical-grade ECG monitor and is being used most often as a way to for people detect recurrent atrial fibrillation. Interpreting Results The main reason for ...

Atrial fibrillation is a common issue for people with ATTR-CM because amyloid proteins build up in the heart and interfere with its ability to pump blood. Afib might not cause noticeable symptoms ...

Sept. 12, 2024 – The number of U.S. adults who have a potentially dangerous irregular heartbeat called atrial fibrillation is triple the number that health experts previously thought, according ...

New prevalence estimates of atrial fibrillation (AF) found that approximately 10.5 million US adults, or 5% of the population, have the condition. 1 The findings, published in the Journal of the ...

Mass screening for atrial fibrillation using ECG together with heart failure biomarker does not prevent ischaemic stroke or systemic embolism (blood clot) in older adults aged 75-76 years over 5 ...